www.jimtrade.com
Menu

Rituximab Injection With Binding Affinity Properties

Rituximab Injection With Binding Affinity Properties

Product Category :    Injections

Supplier                :    CSC Pharmaceuticals

Key Features of Rituximab Injection with Binding Affinity Properties

  • Comprises of a genetically engineered chimeric murine or human monoclonal IgG1 kappa antibody that is directed against CD20 antigen
  • Rituximab Injection has a molecular weight of approximately 145 kD and features binding affinity for CD20 antigen of approximately 8.0 Nm
  • Rituximab Injection is formulated in polysorbate 0.7 mg/mL, sodium chloride 9 mg/mL, sodium citrate dihydrate 7.35 mg/mL and water for injection


Inquire Now
Product Profile of Rituximab Injection with Binding Affinity Properties

Rituximab Injection with Binding Affinity Properties comprises of a genetically engineered chimeric murine or human monoclonal IgG1 kappa antibody that is directed against CD20 antigen. Rituximab Injection has a molecular weight of approximately 145 kD and features binding affinity for CD20 antigen of approximately 8.0 nM. Rituximab Injection is formulated in polysorbate 0.7 mg/mL, sodium chloride 9 mg/mL, sodium citrate dihydrate 7.35 mg/mL and water for injection. Rituximab Injection is. Rituximab Injection with Binding Affinity Properties maintain a pH of 6.5 and finds usage alone or in combination with other medicines for effectively treating non-Hodgkin`s lymphoma which is a type of cancer where it helps the immune system by destroying cancer cells.

Key Features of Rituximab Injection with Binding Affinity Properties
  • Comprises of a genetically engineered chimeric murine or human monoclonal IgG1 kappa antibody that is directed against CD20 antigen
  • Rituximab Injection has a molecular weight of approximately 145 kD and features binding affinity for CD20 antigen of approximately 8.0 Nm
  • Rituximab Injection is formulated in polysorbate 0.7 mg/mL, sodium chloride 9 mg/mL, sodium citrate dihydrate 7.35 mg/mL and water for injection
  • Rituximab Injection maintain a pH of 6.5 and finds usage alone or in combination with other medicines for effectively treating non-Hodgkins lymphoma which is a type of cancer where it helps the immune system by destroying cancer cells
  • Used for treating chronic lymphocytic leukemia (CLL) cancer and when combined with methotrexate, it helps in treating symptoms of rheumatoid arthritis
Recently Updated Products



Ceftazidime 250/500/1000 mg Injection
Ceftazidime 250/500/1000 mg Injection
Supplier    :    Novopharm Formulations Private Limited
Inquire Now
Adrecid IP 500mg Sulfate Injection
Adrecid IP 500mg Sulfate Injection
Supplier    :    Novopharm Formulations Private Limited
Inquire Now
Heavy Current Injection Source
Heavy Current Injection Source
Supplier    :    Sudharsan Insulations
Inquire Now
3 Phase Injection Current Source
3 Phase Injection Current Source
Supplier    :    Sudharsan Insulations
Inquire Now
Quinapyramine Sulphate and Chloride Injection
Quinapyramine Sulphate and Chloride Injection
Supplier    :    Leafsol Systems
Inquire Now